Loading...
Loading...
MASI| Name | Value |
|---|---|
| Revenues | 504.6M |
| Cost of Revenue | 241.4M |
| Gross Profit | 263.2M |
| Operating Expense | 233.1M |
| Operating I/L | 30.1M |
| Other Income/Expense | -18.5M |
| Interest Income | 1.3M |
| Pretax | 11.6M |
| Income Tax Expense | 1.8M |
| Net Income/Loss | 9.8M |
Masimo Corporation develops and markets noninvasive monitoring technologies and hospital automation solutions globally. Its flagship products include Masimo Signal Extraction Technology (SET) pulse oximetry, Masimo rainbow SET platform for noninvasive hemoglobin monitoring, SedLine brain function monitoring technology, capnography and gas monitoring products, O3 regional oximetry, and hemodynamic monitoring solutions. The company also offers Masimo Hospital Automation platform, connectivity devices, nasal high flow ventilation, and neuromodulation solutions. Masimo sells its products through direct sales, distributors, and OEM partners to various healthcare providers and consumers, as well as non-medical products through its e-commerce site, masimopersonalhealth.com.
